KalVista Pharmaceuticals Inc. (KALV) Statistics & Valuation Metrics - Stocknear

KalVista Pharmaceuticals ...

NASDAQ: KALV · Real-Time Price · USD
15.82
0.62 (4.08%)
At close: Sep 05, 2025, 3:59 PM
15.82
0.00%
After-hours: Sep 05, 2025, 07:05 PM EDT

KalVista Pharmaceuticals Statistics

Share Statistics

KalVista Pharmaceuticals has 49.95M shares outstanding. The number of shares has increased by 15.04% in one year.

49.95M
15.04%
0%
99.99%
37.46M
97
0.01%

Short Selling Information

The latest short interest is 10.04M, so 19.94% of the outstanding shares have been sold short.

10.04M
19.94%
22.45%
14.33

Valuation Ratios

The PE ratio is -3.73 and the forward PE ratio is -4.2. KalVista Pharmaceuticals's PEG ratio is -0.51.

-3.73
-4.2
0
21.9
7.17
-4.47
-0.51
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for KalVista Pharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.35, with a Debt / Equity ratio of 0.07.

5.35
5.35
0.07
-0.04
-0.04
-32.5

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.22M
150
0
n/a

Taxes

3.39M
-1.88%

Stock Price Statistics

The stock price has increased by 18.1% in the last 52 weeks. The beta is -0.1, so KalVista Pharmaceuticals's price volatility has been lower than the market average.

-0.1
18.1%
13.66
11.51
67.36
1,229,477

Income Statement

n/a
n/a
-188M
-183.44M
-173.33M
-174.27M
-3.69
Full Income Statement

Balance Sheet

The company has 98.64M in cash and 6.31M in debt, giving a net cash position of 92.34M.

98.64M
6.31M
92.34M
-653.17M
250.77M
196.52M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -152.91M and capital expenditures 0, giving a free cash flow of -152.91M.

-152.91M
n/a
-152.91M
-3.08
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

KALV does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for KALV is $27, which is 77.6% higher than the current price. The consensus rating is "Buy".

$27
77.6%
Buy
8
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Nov 22, 2016. It was a backward split with a ratio of 1:14.

Nov 22, 2016
backward
1:14

Scores

-2.4
1